Patents by Inventor Soren Gregersen

Soren Gregersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
    Patent number: 9636314
    Abstract: A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 2, 2017
    Assignee: Stevia Limited
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen
  • MEDICAMENT FOR TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERTENSION AND/OR METABOLIC SYNDROME
    Publication number: 20140094408
    Abstract: A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.
    Type: Application
    Filed: June 13, 2013
    Publication date: April 3, 2014
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen
  • MEDICAMENT FOR TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERTENSION AND/OR METABOLIC SYNDROME
    Publication number: 20080318866
    Abstract: A substance including the chemical structures of bicyclo [3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo [3.2.1]octan alone or in a kaurene structure provides the substances, such as e.g. steviol, isosteviol and stevioside with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension.
    Type: Application
    Filed: August 7, 2008
    Publication date: December 25, 2008
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix
  • Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
    Publication number: 20080051341
    Abstract: A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo[3.2.1]octan alone or in a kaurene structure provides the substances, such as e.g. steviol, isosteviol and stevioside with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension.
    Type: Application
    Filed: June 28, 2007
    Publication date: February 28, 2008
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Jeppesen
  • Substance for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
    Publication number: 20040081712
    Abstract: A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo[3.2.1]octan alone or in a kaurene structure provides the substances, such as steviol, isosteviol and stevioside, with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension.
    Type: Application
    Filed: July 31, 2003
    Publication date: April 29, 2004
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen, Lars H. Hoie
  • Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
    Publication number: 20030060428
    Abstract: A substance including the chemical structures of bicyclo [3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo [3.2.1]octan alone or in a kaurene structure provides the substances, such as e.g. steviol, isosteviol and stevioside with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension.
    Type: Application
    Filed: July 31, 2002
    Publication date: March 27, 2003
    Inventors: Kjeld Hermansen, Soren Gregersen, Per Jeppesen